"Educated employers are
clearly defining brand, generic and single source drugs in their contract to
prevent the PBM from satisfying their own needs, i.e., freely moving drugs from
one category to the other to increase profits and/or meet contract guarantees."
— Cheryl
Larson, vice president of the Midwest Business Group on Health (MBGH), spoke
with AIS's RADAR on Drug
Benefits about how employers can strategize with PBMs to reach
agreements on drug pricing transparency.
No comments:
Post a Comment